RESEARCH TRIANGLE PARK, NC, August 10, 2016 – G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Medical Officer Raj Malik, MD, will present a company overview at the Wedbush PacGrow Healthcare Conference. The presentation will take place on Wednesday, August 17, at 1:55 p.m. ET at the Le Parker Méridien in New York City.

About G1 Therapeutics, Inc.
G1 Therapeutics is a clinical-stage oncology company developing novel, small-molecule therapies that address significant unmet needs in people with cancer. The company is advancing G1T28, a potential first-in-class drug candidate, and G1T38, a potential best-in-class compound, in multiple oncology indications. G1 is privately held and based in Research Triangle Park, NC.

Visit www.g1therapeutics.com for more information.

###

Contact:                                                              
Gregory Mossinghoff                
G1 Therapeutics                                              
919-251-5980
gjm@g1therapeutics.com      

Media:
Laura Bagby                     
6 Degrees Communications
312-448-8098
lbagby@6degreespr.com